Lenny Dragone

Company: Abata

Job title: Chief Medical Officer

Seminars:

Navigating the Complexities of Disease Indication Selection for Treg Therapies 9:00 am

Acknowledging the unique challenges faced by smaller biotech companies in making strategic decisions when selecting particular disease indications Discussing the implications of disease indication selection on the success of Treg therapies and how this may impact development decisions Offering strategic considerations and decision-making frameworks for smaller biotech’s to capitalize on market opportunityRead more

day: Conference Day Two